Immucell (ICCC) EBT (2010 - 2026)
Immucell's (ICCC) quarterly EBT came in at -$2.8 million in Q4 2025, down 646.65% YoY from $520591.0 in Q4 2024, and down 2003.48% on a QoQ basis from -$135292.0 in Q3 2025.
Immucell (ICCC) EBT (2010 - 2026) Analysis & Trends
Immucell (ICCC) has 16 years of EBT data on file, last reported at -$2.8 million in Q4 2025.
- Quarterly EBT fell 646.65% year-over-year to -$2.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$1.0 million (up 52.09% YoY) and the FY2025 annual result came in at -$1.0 million, up 52.09% from the prior year.
- EBT slipped to -$2.8 million in Q4 2025, from -$135292.0 in the prior quarter.
- In the past five years, EBT ranged from a high of $1.4 million in Q1 2025 to a low of -$2.8 million in Q4 2025.
- A 5-year average of -$575013.0 and a median of -$546257.0 in 2021 frame the typical range for EBT.
- Annual changes were most pronounced in 2022 — EBT slumped 2314.25% — and 2025, when it jumped 431.91%.
- Tracing ICCC's EBT over 5 years: stood at $75256.0 in 2021, then tumbled by 2314.25% to -$1.7 million in 2022, then jumped by 31.68% to -$1.1 million in 2023, then jumped by 145.73% to $520591.0 in 2024, then tumbled by 646.65% to -$2.8 million in 2025.
- The last three EBT figures came in at -$2.8 million (Q4 2025), -$135292.0 (Q3 2025), and $503784.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.39 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.53 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 541.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -767.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 312.46 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 177.81 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -11.37 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 81.49 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -264.70 Mn |
| 10 | Immucell | 92.01 Mn | 83.15 Mn | 2.44 Mn | 1.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.88 Mn |
| Dec 31, 2025 | -2.85 Mn |
| Sep 30, 2025 | -135,292.00 |
| Jun 30, 2025 | 503,784.00 |
| Mar 31, 2025 | 1.45 Mn |
| Dec 31, 2024 | 520,591.00 |
| Sep 30, 2024 | -700,350.00 |
| Jun 30, 2024 | -1.53 Mn |
| Mar 31, 2024 | -436,528.00 |
| Dec 31, 2023 | -1.14 Mn |
| Sep 30, 2023 | -939,771.00 |
| Jun 30, 2023 | -1.38 Mn |
| Mar 31, 2023 | -2.31 Mn |
| Dec 31, 2022 | -1.67 Mn |
| Sep 30, 2022 | -651,211.00 |
| Jun 30, 2022 | -683,000.00 |
| Mar 31, 2022 | 514,435.00 |
| Dec 31, 2021 | 75,256.00 |
| Sep 30, 2021 | 155,807.00 |
| Jun 30, 2021 | 141,113.00 |